Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Tazarotene 0.05% gel |
| BNF code | 1305020T0AAAAAA |
| Virtual Therapeutic Moiety | Tazarotene |
| Date identifier became valid | 19 Oct 2018 |
| Previous product identifier | 332219005 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 18 May 2021 |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Tazarotene |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 500.000 |
| Strength value numerator unit | microgram |
| Strength value denominator | 1.000 |
| Strength value denominator unit | gram |
| Ontology Drug Form & Route | |
| Form & Route | gel.cutaneous |
| Dose Form | |
| Formulation | Cutaneous gel |
| Drug Route | |
| Route | Cutaneous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Virtual Medicinal Product Packs | |
| Tazarotene 0.05% gel 30 gram | |
| Tazarotene 0.05% gel 60 gram | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20250505000001, imported on 5th May 2025 at 04:58:39.